Quick Answer
Evolent Health, Inc. reported Net Income Loss of -$534.51 million for the year ending 2025.
- Evolent Health, Inc. showed a decrease of -767.4% in Net Income Loss from 2024 to 2025.
- This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$5.44 million | Q2 2014: -$5.94 million | Q3 2014: -$3.17 million | Q4 2014: -$10.70 million | Q1 2015: -$11.32 million | Q2 2015: $359.91 million | Q3 2015: -$11.98 million | Q4 2015: -$4.12 million | Q1 2016: -$122.74 million | Q2 2016: -$8.39 million | Q3 2016: -$11.21 million | Q4 2016: -$17.41 million | Q1 2017: -$18.01 million | Q2 2017: -$16.91 million | Q3 2017: -$12.59 million | Q4 2017: -$13.16 million | Q1 2018: -$13.63 million | Q2 2018: -$9.92 million | Q3 2018: -$12.43 million | Q4 2018: -$16.69 million | Q1 2019: -$46.74 million | Q2 2019: -$31.62 million | Q3 2019: -$25.52 million | Q4 2019: -$198.10 million | Q1 2020: -$78.75 million | Q2 2020: -$203.52 million | Q3 2020: -$37.35 million | Q4 2020: -$14.63 million | Q1 2021: -$9.81 million | Q2 2021: -$9.11 million | Q3 2021: -$13.04 million | Q1 2022: -$5.35 million | Q2 2022: -$4.59 million | Q3 2022: $2.12 million | Q1 2023: -$19.98 million | Q2 2023: -$34.32 million | Q3 2023: -$25.32 million | Q4 2023: -$33.41 million | Q1 2024: -$17.28 million | Q2 2024: $1.60 million | Q3 2024: -$23.14 million | Q4 2024: -$22.80 million | Q1 2025: -$64.62 million | Q2 2025: -$19.90 million | Q3 2025: -$20.86 million | Q4 2025: -$429.13 million.
- Over the full 13 years of available data (2013 to 2025), Evolent Health, Inc.'s Net Income Loss has declined by 2,769.5%.
- Historical annual values: Fiscal year 2025: -$534.51 million | Fiscal year 2024: -$61.62 million | Fiscal year 2023: -$113.04 million | Fiscal year 2022: -$19.16 million | Fiscal year 2021: -$37.60 million | Fiscal year 2020: -$334.25 million | Fiscal year 2019: -$301.97 million | Fiscal year 2018: -$52.66 million | Fiscal year 2017: -$60.67 million | Fiscal year 2016: -$159.74 million | Fiscal year 2015: $332.49 million | Fiscal year 2014: -$25.25 million | Fiscal year 2013: $20.02 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: